Injections of a new drug may partially relieve paralyzing spinal cord injuries, based on indications from a study in rats, which was partly funded by the National Institutes of Health.
The results demonstrate how fundamental laboratory research may lead to new therapies.
“We’re very excited at the possibility that millions of people could, one day, regain movements lost during spinal cord injuries,” said Jerry Silver, Ph.D., professor of neurosciences, Case Western Reserve University School of Medicine, Cleveland, and a senior investigator of the study published in Nature.
Every year, tens of thousands of people are paralyzed by spinal cord injuries. The injuries crush and sever the long axons of spinal cord nerve cells, blocking communication between the brain and the body and resulting in paralysis below the injury.
On a hunch, Bradley Lang, Ph.D., the lead author of the study and a graduate student in Dr. Silver’s lab, came up with the idea of designing a drug that would help axons regenerate without having to touch the healing spinal cord, as current treatments may require.
“Originally this was just a side project we brainstormed in the lab,” said Dr. Lang.
After spinal cord injury, axons try to cross the injury site and reconnect with other cells but are stymied by scarring that forms after the injury. Previous studies suggested their movements are blocked when the protein tyrosine phosphatase sigma (PTP sigma), an enzyme found in axons, interacts with chondroitin sulfate proteoglycans, a class of sugary proteins that fill the scars.
Dr. Lang and his colleagues designed a drug called ISP to block the enzyme and facilitate the drug’s entry into the brain and spinal cord. Injections of the drug under the skin of paralyzed rats near the injury site partially restored axon growth and improved movements and bladder functions.
“There are currently no drug therapies available that improve the very limited natural recovery from spinal cord injuries that patients experience,” said Lyn Jakeman, Ph.D., a program director at the NIH’s National Institute of Neurological Disorders and Stroke, Bethesda, MD. “This is a great step towards identifying a novel agent for helping people recover.”
Initially, the goal of the study was to understand how interactions between PTP sigma and chondroitin sulfate proteoglycans prevent axon growth. Drugs were designed to mimic the shape of a critical part of PTP sigma, called the wedge. Different designs were tested on neurons grown in petri dishes alongside impenetrable barriers of proteoglycans. Treatment with ISP freed axon growth.
“It was amazing. The axons kept growing and growing,” said Dr. Silver.
The Latest on: Spinal cord injury
via Google News
The Latest on: Spinal cord injury
- Zebrafish Screening Platform Boosts Spinal Cord Injury Drug Discoveryon July 22, 2019 at 5:18 am
Turning the phrase “a little bait catches a large fish” on its head, a research team from the University of Lisbon is hoping to use a little fish to make a big difference in the field of spinal cord ... […]
- Woman with spinal cord injury, others with disabilities get chance to water skion July 19, 2019 at 3:07 pm
EAST GRAND RAPIDS, MI -- Katie Vree is back water skiing, an activity she once loved. Paralyzed from her waist down, the 25-year-old from Illinois skimmed across Reeds Lake during the Mary Free Bed ... […]
- Boosting the discovery of new drugs to treat spinal cord injuries using zebrafishon July 19, 2019 at 9:08 am
The researchers validated this platform by testing molecules that entered clinical trials for spinal cord injury, namely Riluzole, Minocycline and D-Cycloserine. The results obtained showed that ... […]
- New Nanoparticles Help Spinal Cords to Heal Following Injuryon July 19, 2019 at 7:20 am
a lot of the long-term consequences often stem from the body’s overreaction to the injury. That’s because the blood-brain barrier protecting the spinal cord becomes compromised and overly aggressive ... […]
- A zebrafish drug screening platform boosts the discovery of novel therapeutics for spinal cord injury in mammalson July 19, 2019 at 4:01 am
Spinal cord injury (SCI) is a complex condition, with limited therapeutic options, that results in sensory and motor disabilities. To boost discovery of novel therapeutics, we designed a simple and ... […]
- Kessler Foundation Hosts Conference on Sexuality and Relationships after Spinal Cord Injuryon July 17, 2019 at 8:32 am
A one-day conference for people with spinal cord injury and their loved ones was followed by a half-day workshop for spinal cord injury professionals. EAST HANOVER, N.J., July 10, 2019 /PRNewswire ... […]
- EpiPen Prevents Spinal Cord Damage and Paralysison July 12, 2019 at 6:29 am
EpiPen helps prevent spinal cord injury from leading to paralysis to a loss of sensation, promoting a therapeutic response. An injection of nanoparticles can prevent the body's immune system from ... […]
- An ‘EpiPen’ for spinal cord injuries could prevent paralysison July 12, 2019 at 2:25 am
But for the some 12,000 new cases of spinal cord injury in the US annually, the body’s immune system can often do more harm than good, causing nerve damage, numbness, even paralysis. With this ... […]
- An injection of nanoparticles for spinal cord injurieson July 11, 2019 at 7:44 pm
The study titled, “Intravascular innate immune cells reprogrammed via intravenous nanoparticles to promote functional recovery after spinal cord injury,” was published in the latest issue of the ... […]
- An 'EpiPen' for spinal cord injurieson July 11, 2019 at 8:43 am
A spinal cord injury breaks that barrier, letting in overzealous immune cells that create too much inflammation for the delicate neural tissues. That leads to the rapid death of neurons ... […]
via Bing News